ABS Direct Equity Fund LLC Takes $263,000 Position in Astera Labs, Inc. $ALAB

ABS Direct Equity Fund LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 1st quarter, Holdings Channel.com reports. The institutional investor purchased 2,400 shares of the company’s stock, valued at approximately $263,000.

Other large investors also recently added to or reduced their stakes in the company. Atreides Management LP raised its stake in Astera Labs by 2,496.6% in the 4th quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock valued at $268,038,000 after acquiring an additional 1,549,144 shares during the period. Amundi boosted its position in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership purchased a new position in shares of Astera Labs in the fourth quarter worth about $148,980,000. Goldman Sachs Group Inc. increased its stake in shares of Astera Labs by 189.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after purchasing an additional 858,693 shares in the last quarter. Finally, State Street Corp raised its position in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In related news, Director Manuel Alba sold 8,491 shares of the business’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the completion of the transaction, the director directly owned 286,863 shares in the company, valued at $131,492,261.94. The trade was a 2.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the transaction, the director owned 75,688 shares in the company, valued at $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,676,845 shares of company stock valued at $444,928,806 in the last ninety days. 10.40% of the stock is owned by insiders.

Astera Labs Stock Performance

Astera Labs stock opened at $291.58 on Monday. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The firm has a market capitalization of $49.98 billion, a PE ratio of 197.01, a price-to-earnings-growth ratio of 3.38 and a beta of 3.66. The firm’s 50 day simple moving average is $358.95 and its 200 day simple moving average is $226.07.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same period last year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts forecast that Astera Labs, Inc. will post 1.86 earnings per share for the current year.

Wall Street Analyst Weigh In

ALAB has been the topic of a number of recent research reports. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. UBS Group increased their target price on Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a research report on Monday, June 29th. Barclays raised their price target on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Jefferies Financial Group reiterated a “buy” rating and issued a $270.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Roth Capital reiterated a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average price target of $282.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.